Skip to main content
padlock icon - secure page this page is secure

Why is optimisation of antimicrobial use difficult at the end of life?

Buy Article:

$52.00 + tax (Refund Policy)

The antibiotic optimisation imperative is now ubiquitous, with national policy frameworks in Organisation for Economic Co‐operation and Development (OECD) countries incorporating the requirement for antimicrobial stewardship within healthcare services. Yet in practice, the optimisation agenda often raises complex ethical‐ and practice‐based dilemmas. Antibiotic use at the end of life is multidimensional. It includes balancing complex issues, such as accuracy of prognostic estimates, benevolence to the individual versus the broader public health, personalised value judgement of time and quality of life and the right to treatment versus the right to die. It also occurs in an emotional context where the clinician and patient (and their family) collectively confront mortality. This provides a scenario where amplification of the already strong social and behavioural forces that drive overuse of antibiotics in many other clinical settings may occur. It therefore offers an important case for illustrating how antibiotic optimisation may be limited by social, value‐based and ethical dilemmas.
No References
No Citations
No Supplementary Data
No Article Media
No Metrics

Keywords: antimicrobial resistance; antimicrobial stewardship; palliative care

Document Type: Research Article

Publication date: February 1, 2019

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more